{"id":"W2765660745","doi":"10.1111/1755-5922.12308","title":"Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin","year":2017,"lang":"en","type":"article","venue":"Cardiovascular Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Tolerability; PCSK9; Placebo; Internal medicine; Clinical endpoint; Gastroenterology; Statin; Adverse effect; Kexin; Endocrinology; Urology; Pharmacology; Randomized controlled trial; Lipoprotein; Cholesterol; LDL receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008628375,0.0005123971,0.001949952,0.0002382933,0.00017557,0.00004760335,0.0003112799,0.0002613843,0.000007370174],"category_scores_gemma":[0.00006569727,0.0003893232,0.0008775208,0.0001512854,0.0003142697,0.00009423955,0.00006403069,0.0003875333,0.000005215786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000348466,"about_ca_system_score_gemma":0.0007084937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001744697,"about_ca_topic_score_gemma":0.0001360326,"domain_scores_codex":[0.9967531,0.0004422878,0.000653043,0.0006562138,0.0009433483,0.0005519928],"domain_scores_gemma":[0.99665,0.00009041034,0.0003971957,0.002363512,0.0003094948,0.000189433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02632939,0.005135797,0.03328121,0.008158408,0.0331836,0.003253266,0.008461036,0.0003859147,0.3920395,0.0003100926,0.000004172401,0.4894576],"study_design_scores_gemma":[0.06636836,0.02618978,0.2613966,0.003790269,0.006081739,0.0004621684,0.000501683,0.0003494881,0.6313826,0.00009923186,0.002346314,0.001031768],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904866,0.00527353,0.0002198076,0.00007117149,0.0001767309,0.003593143,0.00002421352,0.00003835475,0.000116452],"genre_scores_gemma":[0.9973416,0.001182518,0.0008447443,0.0001035603,0.0001832371,0.0001293221,0.00006150064,0.0001112849,0.000042189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4884258,"threshold_uncertainty_score":0.9998559,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03117708978944782,"score_gpt":0.2941826839491778,"score_spread":0.26300559415973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}